Publicacións en colaboración con investigadores/as de French Institute of Health and Medical Research (23)

2023

  1. Oligo-Metastatic Cancers: Putative Biomarkers, Emerging Challenges and New Perspectives

    Cancers, Vol. 15, Núm. 6

2022

  1. Mapping genomic loci implicates genes and synaptic biology in schizophrenia

    Nature, Vol. 604, Núm. 7906, pp. 502-508

2020

  1. Alcohol exposure–induced neurovascular inflammatory priming impacts ischemic stroke and is linked with brain perivascular macrophages

    JCI Insight, Vol. 5, Núm. 4

  2. Premorbid Adjustment and IQ in Patients with First-Episode Psychosis: A Multisite Case-Control Study of Their Relationship with Cannabis Use

    Schizophrenia Bulletin, Vol. 46, Núm. 3, pp. 517-529

2019

  1. Cellular Senescence: Defining a Path Forward

    Cell, Vol. 179, Núm. 4, pp. 813-827

  2. The Tumor Suppressor SASH1 Interacts With the Signal Adaptor CRKL to Inhibit Epithelial–Mesenchymal Transition and Metastasis in Colorectal Cancer

    Cellular and Molecular Gastroenterology and Hepatology, Vol. 7, Núm. 1, pp. 33-53

2018

  1. Erratum to: Obestatin controls skeletal muscle fiber-type determination (Scientific Reports, (2017), 7, 1, (2137), 10.1038/s41598-017-02337-4)

    Scientific Reports

  2. Improvement of Duchenne muscular dystrophy phenotype following obestatin treatment

    Journal of Cachexia, Sarcopenia and Muscle, Vol. 9, Núm. 6, pp. 1063-1078

2017

  1. Obestatin Increases the Regenerative Capacity of Human Myoblasts Transplanted Intramuscularly in an Immunodeficient Mouse Model

    Molecular Therapy, Vol. 25, Núm. 10, pp. 2345-2359

  2. Obestatin controls skeletal muscle fiber-type determination

    Scientific Reports, Vol. 7, Núm. 1

  3. Obestatin controls the ubiquitin–proteasome and autophagy–lysosome systems in glucocorticoid-induced muscle cell atrophy

    Journal of Cachexia, Sarcopenia and Muscle, Vol. 8, Núm. 6, pp. 974-990

2016

  1. β-Arrestin scaffolds and signaling elements essential for the obestatin/GPR39 system that determine the myogenic program in human myoblast cells

    Cellular and Molecular Life Sciences, Vol. 73, Núm. 3, pp. 617-635

2009

  1. WNT16B is a new marker of cellular senescence that regulates p53 activity and the phosphoinositide 3-kinase/AKT pathway

    Cancer Research, Vol. 69, Núm. 24, pp. 9183-9191

2006

  1. Adenosine does not bind to the growth hormone secretagogue receptor type-1a (GHS-R1a)

    Journal of Endocrinology, Vol. 191, Núm. 1, pp. 147-157

2004

  1. Desensitization and Endocytosis Mechanisms of Ghrelin-Activated Growth Hormone Secretagogue Receptor 1a

    Endocrinology, Vol. 145, Núm. 2, pp. 930-940

  2. GH prevents apostosis in cardiomyocytes cultured in vitro through a calcineurin-dependent mechanism

    Journal of Endocrinology, Vol. 180, Núm. 2, pp. 325-335

1998

  1. Grb10 identified as a potential regulator of growth hormone (GH) signaling by cloning of GH receptor target proteins

    Journal of Biological Chemistry, Vol. 273, Núm. 26, pp. 15906-15912

1997

  1. Dominant negative and cooperative effects of mutant forms of prolactin receptor

    Molecular Endocrinology, Vol. 11, Núm. 8, pp. 1020-1032

  2. Internalization of prolactin receptor and prolactin in transfected cells does not involve nuclear translocation

    Journal of Cell Science, Vol. 110, Núm. 9, pp. 1123-1132

  3. Prolactin activates tyrosyl phosphorylation of insulin receptor substrate 1 and phosphatidylinositol-3-OH kinase

    Journal of Biological Chemistry, Vol. 272, Núm. 4, pp. 2050-2052